Report from Egypt's AmpleLogic Pharma Summit 2023

2 March 2023

A report from the second edition of the AmpleLogic Pharma Summit, held last month at Hilton Cairo Heliopolis in Egypt.

The event attracted more than 120 industry’s leaders and experts from the Middle East and North Africa (MENA) region and was aimed at empowering the acceleration of their digital transformation processes and enhancing its role in pharmaceutical quality development.

This edition's strapline was: Bridge the Digital Gap in Lifesciences Industry in the Mena Region’. It was emphasized that pharma leaders need to be ready to manage uncertainty, while preparing to scale for the future and know how new-age digital technologies can help mitigate regulatory challenges.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK